BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28267478)

  • 1. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.
    Chamberlain AM; Alonso A; Gersh BJ; Manemann SM; Killian JM; Weston SA; Byrne M; Roger VL
    Am Heart J; 2017 Mar; 185():74-84. PubMed ID: 28267478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Heart Failure in the Community: Differences by Age and Ejection Fraction.
    Chamberlain AM; Boyd CM; Manemann SM; Dunlay SM; Gerber Y; Killian JM; Weston SA; Roger VL
    Am J Med; 2020 Jun; 133(6):e237-e248. PubMed ID: 31747542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.
    Claxton JS; Chamberlain AM; Lutsey PL; Chen LY; MacLehose RF; Bengtson LGS; Alonso A
    Am J Med; 2020 Oct; 133(10):e554-e567. PubMed ID: 32320695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of chronic obstructive pulmonary disease on prognosis in atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry.
    Proietti M; Laroche C; Drozd M; Vijgen J; Cozma DC; Drozdz J; Maggioni AP; Boriani G; Lip GY;
    Am Heart J; 2016 Nov; 181():83-91. PubMed ID: 27823697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.
    Loring Z; Shrader P; Allen LA; Blanco R; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Mahaffey KW; Naccarelli GV; Pieper K; Reiffel JA; Singer DE; Steinberg BA; Thomas LE; Peterson ED; Piccini JP
    Am Heart J; 2020 Jan; 219():21-30. PubMed ID: 31710841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Prediction Model for Atrial Fibrillation Using Electronic Health Records.
    Hulme OL; Khurshid S; Weng LC; Anderson CD; Wang EY; Ashburner JM; Ko D; McManus DD; Benjamin EJ; Ellinor PT; Trinquart L; Lubitz SA
    JACC Clin Electrophysiol; 2019 Nov; 5(11):1331-1341. PubMed ID: 31753441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socioeconomic Status as a Predictor of Mortality in Patients Admitted With Atrial Fibrillation.
    Kargoli F; Shulman E; Aagaard P; Briceno DF; Hoch E; Di Biase L; Fisher JD; Gross J; Kim SG; Krumerman A; Ferrick KJ
    Am J Cardiol; 2017 May; 119(9):1378-1381. PubMed ID: 28400027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between atrial fibrillation and stroke in patients with obstructive sleep apnea: a population-based case-control study.
    Mansukhani MP; Calvin AD; Kolla BP; Brown RD; Lipford MC; Somers VK; Caples SM
    Sleep Med; 2013 Mar; 14(3):243-6. PubMed ID: 23340087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Blacks Versus Whites with Cardiomyopathy.
    Khan S; Mulukutla S; Thoma F; Bhonsale A; Kancharla K; Estes Iii NAM; Jain SK; Saba S
    Am J Cardiol; 2021 Jun; 148():151-156. PubMed ID: 33667452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.
    Vermond RA; Geelhoed B; Verweij N; Tieleman RG; Van der Harst P; Hillege HL; Van Gilst WH; Van Gelder IC; Rienstra M
    J Am Coll Cardiol; 2015 Sep; 66(9):1000-7. PubMed ID: 26314526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk factors of atrial fibrillation in Asian COPD patients.
    Liao KM; Chen CY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2523-2530. PubMed ID: 28883719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus as risk factor for atrial fibrillation hospitalization: Incidence and outcomes over nine years in a region of Northern Italy.
    Staszewsky L; Cortesi L; Baviera M; Tettamanti M; Marzona I; Nobili A; Fortino I; Bortolotti A; Merlino L; Disertori M; Latini R; Roncaglioni MC
    Diabetes Res Clin Pract; 2015 Sep; 109(3):476-84. PubMed ID: 26220013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease: a report from the EURObservational research programme pilot survey on atrial fibrillation.
    Proietti M; Raparelli V; Laroche C; Dan GA; Janion M; Popescu R; Sinagra G; Vijgen J; Boriani G; Maggioni AP; Tavazzi L; Lip GYH;
    Europace; 2017 Sep; 19(9):1439-1448. PubMed ID: 27940934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable or higher prevalence of comorbidities in antiphospholipid syndrome vs rheumatoid arthritis: a multicenter, case-control study.
    Panopoulos S; Thomas K; Georgiopoulos G; Boumpas D; Katsiari C; Bertsias G; Drosos AA; Boki K; Dimitroulas T; Garyfallos A; Papagoras C; Katsimbri P; Tziortziotis A; Adamichou C; Kaltsonoudis E; Argyriou E; Vosvotekas G; Sfikakis PP; Vassilopoulos D; Tektonidou MG
    Rheumatology (Oxford); 2021 Jan; 60(1):170-178. PubMed ID: 32596727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality, Hospitalization, and Cardiac Interventions in Patients With Atrial Fibrillation Aged <65 Years.
    Bhonsale A; Zhu J; Thoma F; Koscumb S; Kancharla K; Voigt A; Magnani J; Estes NA; Saba S; Marroquin O; Mulukutla S; Jain S
    Circ Arrhythm Electrophysiol; 2024 May; 17(5):e012143. PubMed ID: 38646831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of multiple comorbidities on mortality in chronic obstructive pulmonary disease among Korean population: a nationwide cohort study.
    Kim Y; Kim YJ; Cho WK
    BMC Pulm Med; 2021 Feb; 21(1):56. PubMed ID: 33573635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and ≥60 years.
    Kim IS; Choi YJ; Choi EY; Min PK; Yoon YW; Lee BK; Hong BK; Rim SJ; Kwon HM; Kim JY
    PLoS One; 2021; 16(11):e0258770. PubMed ID: 34793457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women].
    Rodríguez-Reyes H; Laguna-Muñoz CI; Gallegos-de Luna CF; de-Los-Ríos-Ibarra MO; Salas-Pacheco JL; Leyva-Pons JL; Muñoz-Gutiérrez LM; Vargas-Hernandez A; Rodríguez-Muñoz KM; Barragán-Luna J; Alcocer-Gamba MA; Cortez-Lawrenz J; Farjat-Ruiz J
    Arch Cardiol Mex; 2022 Jul; 92(3):349-357. PubMed ID: 34758015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation in patients hospitalized with acute myocardial infarction: analysis of the china acute myocardial infarction (CAMI) registry.
    Dai Y; Yang J; Gao Z; Xu H; Sun Y; Wu Y; Gao X; Li W; Wang Y; Gao R; Yang Y;
    BMC Cardiovasc Disord; 2017 Jan; 17(1):2. PubMed ID: 28052755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Ullal AJ; Kaiser DW; Fan J; Schmitt SK; Than CT; Winkelmayer WC; Heidenreich PA; Piccini JP; Perez MV; Wang PJ; Turakhia MP
    J Cardiovasc Electrophysiol; 2017 Jan; 28(1):39-48. PubMed ID: 27782345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.